These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6793711)

  • 1. Adrenochrome-induced coronary artery constriction in the rat heart.
    Karmazyn M; Beamish RE; Fliegel L; Dhalla NS
    J Pharmacol Exp Ther; 1981 Oct; 219(1):225-30. PubMed ID: 6793711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of calcium in coronary vasoconstriction due to prolonged hypoxia.
    Karmazyn M; Beamish RE; Dhalla NS
    Am Heart J; 1984 Feb; 107(2):293-7. PubMed ID: 6141719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of reducing agents on adrenochrome-induced changes in the heart.
    Singal PK; Yates JC; Beamish RE; Dhalla NS
    Arch Pathol Lab Med; 1981 Dec; 105(12):664-9. PubMed ID: 6895456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenochrome uptake and subcellular distribution in the isolated perfused rat heart.
    Fliegel L; Takeo S; Beamish RE; Dhalla NS
    Can J Cardiol; 1985 Mar; 1(2):122-7. PubMed ID: 3850768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of adrenochrome-induced cardiac contractile failure and cell damage by changes in cation concentrations.
    Yates JC; Taam GM; Singal PK; Beamish RE; Dhalla NS
    Lab Invest; 1980 Oct; 43(4):316-26. PubMed ID: 7442122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling mechanisms for muscarinic receptor-mediated coronary vasoconstriction in isolated rat hearts.
    Zhang Y; Hoover DB
    J Pharmacol Exp Ther; 2000 Apr; 293(1):96-106. PubMed ID: 10734158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
    Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
    Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of the vasorelaxant effect of 1-hydroxy-2, 3, 5-trimethoxy-xanthone, isolated from a Tibetan herb, Halenia elliptica, on rat coronary artery.
    Wang Y; Shi JG; Wang MZ; Che CT; Yeung JH
    Life Sci; 2007 Sep; 81(12):1016-23. PubMed ID: 17822718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ostreolysin induces sustained contraction of porcine coronary arteries and endothelial dysfunction in middle- and large-sized vessels.
    Juntes P; Rebolj K; Sepcić K; Macek P; Zuzek MC; Cestnik V; Frangez R
    Toxicon; 2009 Nov; 54(6):784-92. PubMed ID: 19524606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodilator action of KB-944, a new calcium antagonist.
    Morita T; Yoshino K; Kanazawa T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil: a selective antagonist of constrictor substances in dog coronary artery: implications for variant angina.
    Angus JA; Brazenor RM; Le Duc MA
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():15-28. PubMed ID: 6956474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nonsteroidal anti-inflammatory drugs on the hypoxic rat heart.
    Karmazyn M; Pierce GN; Williams S
    J Pharmacol Exp Ther; 1981 Aug; 218(2):488-96. PubMed ID: 7252848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity induced by androsterone and hemisuccinate of androsterone on perfusion pressure and vascular resistance].
    Figueroa L; Díaz F; Camacho A; Díaz E; Marvin R
    Biomedica; 2009 Dec; 29(4):625-34. PubMed ID: 20440461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
    Sawmiller DR; Henning RJ; Cuevas J; Dehaven WI; Vesely DL
    Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia inhibits vasoconstriction induced by metabotropic Ca2+ channel-induced Ca2+ release in mammalian coronary arteries.
    Calderón-Sánchez E; Fernández-Tenorio M; Ordóñez A; López-Barneo J; Ureña J
    Cardiovasc Res; 2009 Apr; 82(1):115-24. PubMed ID: 19131363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the role of superoxide anion radicals for the cardiotoxicity of adrenochrome.
    Rump AF; Schierholz J; Rösen R; Güttler K; Klaus W
    Arzneimittelforschung; 2001; 51(12):964-70. PubMed ID: 11799843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the possible involvement of Ca2+ entry blockade in the relaxation by class I antiarrhythmic drugs in the isolated pig coronary smooth muscle.
    Tanaka Y; Kamibayashi M; Yamashita Y; Imai T; Tanaka H; Nakahara T; Ishii K; Shigenobu K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):56-66. PubMed ID: 11862334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamine-induced myocardial cell damage: catecholamines or adrenochrome.
    Wheatley AM; Thandroyen FT; Opie LH
    J Mol Cell Cardiol; 1985 Apr; 17(4):349-59. PubMed ID: 4020875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.